The latest food and beverage industry news and trend analysis

Onego Bio, the food ingredient company specialising in the production of non-animal egg protein through precision fermentation, has announced the appointment of Dr. Antti Vasara to its Board of Directors.

The addition of Dr. Vasara brings over 25 years of global experience in science, technology, and commercial strategy to the company's governance structure. His arrival comes at a pivotal moment as Onego Bio advances the commercial rollout of its flagship product, Bioalbumen®.

Strengthening the Strategic Core

Dr. Vasara is a heavyweight figure in the European deep tech landscape. Most recently, he served as President and CEO of VTT Technical Research Centre of Finland, leading one of the continent's foremost research organisations. His career also includes senior leadership roles at Nokia and significant contributions to European research and development policy.

Maija Itkonen, CEO of Onego Bio, emphasised that Dr. Vasara’s specific expertise in scaling technology is critical for the company's next phase.

“Antti is one of the most respected leaders in science and innovation,” Itkonen stated. “His deep understanding of technology commercialisation and ecosystem-level strategy will be invaluable as Onego accelerates its mission to deliver resilient, sustainable ingredients at scale.”

Commercial Context: Scaling Bioalbumen®

Onego Bio is currently focused on the industrial scaling of Bioalbumen®, a bio-identical egg protein produced without chickens. The ingredient is designed to match the taste, nutrition, and functionality of traditional egg whites while offering food manufacturers a stable supply chain free from avian flu volatility and a significantly reduced environmental footprint.

The company reports that the ingredient is already gaining traction across the food manufacturing, baking, and consumer packaged goods (CPG) sectors.

Commenting on his appointment, Dr. Vasara highlighted the industrial viability of Onego's approach as a key motivator.

“Onego Bio is not just redesigning food ingredients—it is delivering industrial‑scale solutions grounded in science and built for efficiency,” said Dr. Vasara. “I’m excited to contribute to a team that is solving real supply chain challenges with technology that’s both scalable and globally needed.”